EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 02021R0620-20230605

Consolidated text: Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)Text with EEA relevance

ELI: http://data.europa.eu/eli/reg_impl/2021/620/2023-06-05

02021R0620 — EN — 05.06.2023 — 006.001


This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document

►B

COMMISSION IMPLEMENTING REGULATION (EU) 2021/620

of 15 April 2021

laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases

(Text with EEA relevance)

(OJ L 131 16.4.2021, p. 78)

Amended by:

 

 

Official Journal

  No

page

date

►M1

COMMISSION IMPLEMENTING REGULATION (EU) 2021/1008 of 21 June 2021

  L 222

12

22.6.2021

►M2

COMMISSION IMPLEMENTING REGULATION (EU) 2021/1911 of 27 October 2021

  L 389

2

4.11.2021

►M3

COMMISSION IMPLEMENTING REGULATION (EU) 2022/214 of 17 February 2022

  L 37

16

18.2.2022

►M4

COMMISSION IMPLEMENTING REGULATION (EU) 2022/1218 of 14 July 2022

  L 188

65

15.7.2022

►M5

COMMISSION IMPLEMENTING REGULATION (EU) 2023/150 of 20 January 2023

  L 20

33

23.1.2023

►M6

COMMISSION IMPLEMENTING REGULATIONZ (EU) 2023/1071 of 1 June 2023

  L 143

105

2.6.2023




▼B

COMMISSION IMPLEMENTING REGULATION (EU) 2021/620

of 15 April 2021

laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases

(Text with EEA relevance)



Article 1

Subject matter and scope

1.  
This Regulation lays down implementing rules for the listed diseases referred to in Article 9(1)(a), (b) and (c) of Regulation (EU) 2016/429 of animals, as regards the disease-free and non-vaccination status of certain Member States ( 1 ) or zones or compartments thereof, and the approval of eradication programmes for those listed diseases.
2.  
The Annexes to this Regulation list both the Member States or zones or compartments thereof whose disease-free status or eradication programmes shall be deemed to be approved as provided for in Article 280 of Regulation (EU) 2016/429, and those whose disease-free status and eradication programmes shall be duly approved by this Regulation and also duly listed in the Annexes thereto.
3.  

This Regulation lists in the Annexes thereto:

(a) 

the Member States or zones or compartments thereof with approved compulsory eradication programmes for Category B diseases and optional eradication programmes for Category C diseases.

(b) 

the Member States or zones thereof with approved disease-free status and non-vaccination status;

(c) 

the compartments of Member States with recognised disease-free status.

Article 2

Infection with Brucella abortus, B. melitensis and B. suis

1.  
The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations shall be listed in Chapter 1 of Part I of Annex I.
2.  
The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations shall be listed in Chapter 2 of Part I of Annex I.

▼M3

3.  
The Member States or zones thereof with an approved compulsory eradication programme for infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations shall be listed in Chapter 1 of Part II of Annex I.
4.  
The Member States or zones thereof with an approved compulsory eradication programme for infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations shall be listed in Chapter 2 of Part II of Annex I.

▼B

Article 3

Infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) (MTBC)

1.  
The Member States or zones thereof with disease-free status from infection with Mycobacterium tuberculosis complex (Mycobacterium bovis, M.caprae and M. tuberculosis) (MTBC) shall be listed in Part I of Annex II.
2.  
The Member States or zones thereof with an approved compulsory eradication programme for infection with MTBC shall be listed in Part II of Annex II.

Article 4

Infection with rabies virus (RABV)

1.  
The Member States or zones thereof with disease-free status from infection with rabies virus (RABV) shall be listed in Part I of Annex III.
2.  
The Member States or zones thereof with an approved compulsory eradication programme for infection with RABV shall be listed in Part II of Annex III.

Article 5

Enzootic bovine leukosis (EBL)

1.  
The Member States or zones thereof with disease-free status from enzootic bovine leukosis (EBL) shall be listed in Part I of Annex IV.
2.  
The Member States or zones thereof with an approved optional eradication programme for EBL shall be listed in Part II of Annex IV.

Article 6

Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV)

1.  
The Member States or zones thereof with disease-free status from infectious bovine rinotracheitis/infectious pustular vulvovaginitis (IBR/IPV) shall be listed in Part I of Annex V.
2.  
The Member States or zones thereof with an approved optional eradication programme for IBR/IPV shall be listed in Part II of Annex V.

Article 7

Infection with Aujeszky’s disease virus(ADV)

1.  
The Member States or zones thereof with disease-free status from infection with Aujeszky’s disease virus (ADV) shall be listed in Part I of Annex VI.
2.  
The Member States or zones thereof with an approved optional eradication programme for infection with ADV shall be listed in Part II of Annex VI.

Article 8

Bovine viral diarrhoea (BVD)

1.  
The Member States or zones thereof with disease-free status from Bovine viral diarroea (BVD) shall be listed in Part I of Annex VII.
2.  
The Member States or zones thereof with an approved optional eradication programme for infection with BVD shall be listed in Part II of Annex VII.

Article 9

Infection with bluetongue virus (serotypes 1-24) (infection with BTV)

1.  
The Member States or zones thereof with disease-free status from infection with bluetongue virus (serotypes 1-24) (infection with BTV) shall be listed in Part I of Annex VIII.
2.  
The Member States or zones thereof with an approved optional eradication programme for infection with BTV shall be listed in Part II of Annex VIII.

Article 10

Infestation with Varroa spp.

The Member States or zones thereof with disease-free status from infestation with Varroa spp. shall be listed in Annex IX.

Article 11

Infection with Newcastle disease virus

The Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination shall be listed in Annex X.

Article 12

Infection with highly pathogenic avian influenza (HPAI)

Compartments of the Member States free from HPAI shall be listed in Annex XI.

Article 13

Viral haemorrhagic septicaemia (VHS)

1.  

The following shall be listed in Part I of Annex XII:

(a) 

Member States where their whole territory has disease-free status from viral haemorrhagic septicaemia (VHS);

(b) 

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and

(c) 

zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2.  

The following shall be listed in Part II of Annex XII:

(a) 

Member States where their whole territory has an approved eradication programme for VHS;

(b) 

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS; and

(c) 

zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 14

Infectious haematopoietic necrosis (IHN)

1.  

The following shall be listed in Part I of Annex XIII:

(a) 

Member States where their whole territory has disease-free status from infectious haematopoietic necrosis (IHN);

(b) 

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN; and

(c) 

zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2.  

The following shall be listed in Part II of Annex XIII:

(a) 

Member States where their whole territory has an approved eradication programme for IHN;

(b) 

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and

(c) 

zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 15

Infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV)

1.  

The following shall be listed in Part I of Annex XIV:

(a) 

Member States where their whole territory has disease-free status from infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV);

(b) 

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and

(c) 

zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2.  

The following shall be listed in Part II of Annex XIV:

(a) 

Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;

(b) 

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and

(c) 

zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 16

Infection with Marteilia refringens

1.  

The following shall be listed in Part I of Annex XV:

(a) 

Member States where their whole territory has disease-free status from infection with Marteilia refringens;

(b) 

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and

(c) 

zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2.  

The following shall be listed in Part II of Annex XV:

(a) 

Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens;

(b) 

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and

(c) 

zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 17

Infection with Bonamia exitiosa

1.  

The following shall be listed in Part I of Annex XVI:

(a) 

Member States where their whole territory has disease-free status from infection with Bonamia exitiosa;

(b) 

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and

(c) 

zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2.  

The following shall be listed in Part II of Annex XVI:

(a) 

Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa;

(b) 

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and

(c) 

zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 18

Infection with Bonamia ostreae

1.  

The following shall be listed in Part I of Annex XVII:

(a) 

Member States where their whole territory has disease-free status from infection with Bonamia ostreae;

(b) 

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and

(c) 

zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2.  

The following shall be listed in Part II of Annex XVII:

(a) 

Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae;

(b) 

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and

(c) 

zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 19

Infection with white spot syndrome virus (WSSV)

1.  

The following shall be listed in Part I of Annex XVIII:

(a) 

Member States where their whole territory has disease-free status from infection with white spot syndrome virus (WSSV);

(b) 

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and

(c) 

zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

2.  

The following shall be listed in Part II of Annex XVIII:

(a) 

Member States where their whole territory has an approved eradication programme for infection with WSSV;

(b) 

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and

(c) 

zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 20

Repeal

The following acts are repealed:

— 
Decision 93/52/EEC,
— 
Decision 94/963/EC,
— 
Decision 95/98/EC,
— 
Decision 2003/467/EC,
— 
Decision 2004/558/EC,
— 
Decision 2008/185/EC,
— 
Decision 2009/177/EC,
— 
Regulation (EC) No 616/2009,
— 
Implementing Decision 2013/503/EU.

Article 21

Entry into force and application

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

It shall apply from 21 April 2021.

This Regulation shall be binding in its entirety and directly applicable in all Member States.




ANNEX I

INFECTION WITH BRUCELLA ABORTUS, B. MELITENSIS AND B. SUIS

PART I

Disease-free status from infection with Brucella abortus, B. melitensis and B. suis

CHAPTER 1

Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations



Member State (*1)

Territory

Belgium

Whole territory

Czechia

Whole territory

Denmark

Whole territory

Germany

Whole territory

Estonia

Whole territory

Ireland

Whole territory

▼M3

Spain

Whole territory

▼B

France

Whole territory

▼M1

Croatia

Whole territory

▼M6

Italy

Regione Abruzzo: Provincia di Pescara, Teramo

Regione Basilicata: Provincia di Matera

Regione Calabria: Provincia di Vibo Valentia

Regione Campania: Provincia di Avellino, Benevento, Napoli

Regione Emilia-Romagna

Regione Friuli Venezia Giulia

Regione Lazio

Regione Liguria

Regione Lombardia

Regione Marche

Regione Molise: Provincia di Campobasso

Regione Piemonte

Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce

Regione Sardegna

Regione Toscana

Regione Trentino – Alto Adige

Regione Umbria

Regione Valle d’Aosta

Regione Veneto

▼B

Cyprus

Whole territory

Latvia

Whole territory

Lithuania

Whole territory

Luxembourg

Whole territory

Malta

Whole territory

Netherlands

Whole territory

Austria

Whole territory

Poland

Whole territory

▼M6

Portugal

Distritos Aveiro, Castelo Branco, Coimbra, Faro, Guarda, Leiria, Santarem, Setubal, Viseu

Região Autónoma dos Açores: Ilhas de Corvo, Faial, Flores, Graciosa, Pico, São Jorge, Santa Maria, Terceira

▼B

Romania

Whole territory

Slovenia

Whole territory

Slovakia

Whole territory

Finland

Whole territory

Sweden

Whole territory

United Kingdom (Northern Ireland)

Northern Ireland

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

▼M4

CHAPTER 2

Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations



Member State (*1)

Territory

Belgium

Whole territory

Czechia

Whole territory

Denmark

Whole territory

Germany

Whole territory

Estonia

Whole territory

Ireland

Whole territory

Spain

Whole territory

▼M6

France

Whole territory

Italy

Regione Abruzzo

Regione Calabria: Province di Catanzaro, Cosenza

Regione Campania: Provincia di Benevento, Napoli, Salerno

Regione Emilia-Romagna

Regione Friuli Venezia Giulia

Regione Lazio

Regione Liguria

Regione Lombardia

Regione Marche

Regione Molise

Regione Piemonte

Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto

Regione Sardegna

Regione Toscana

Regione Trentino – Alto Adige

Regione Umbria

Regione Valle d’Aosta

Regione Veneto

▼M4

Cyprus

Whole territory

Latvia

Whole territory

Lithuania

Whole territory

Luxembourg

Whole territory

Hungary

Whole territory

Netherlands

Whole territory

Austria

Whole territory

Poland

Whole territory

Portugal

Região Autónoma dos Açores

Romania

Whole territory

Slovenia

Whole territory

Slovakia

Whole territory

Finland

Whole territory

Sweden

Whole territory

United Kingdom (Northern Ireland)

Northern Ireland

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

▼M3

PART II

Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis

CHAPTER 1

Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in bovine animal populations



Member State

Territory

Bulgaria

Whole territory

Greece

Whole territory

Hungary

Whole territory

▼M6

Italy

Regione Abruzzo: Provincia dell’Aquila, di Chieti

Regione Basilicata: Provincia di Potenza

Regione Calabria: Provincia di Catanzaro, Cosenza, Crotone, Reggio Calabria

Regione Campania: Provincia di Caserta, Salerno

Regione Molise: Provincia di Isernia

Regione Puglia: Provincia di Foggia, Taranto

Regione Sicilia

Portugal

Distritos Beja, Braga, Braganca, Evora, Lisboa, Portalegre, Porto, Viana do Castelo, Vila Real

Região Autónoma da Madeira

Região Autónoma dos Açores: Ilha de São Miguel

▼M3

CHAPTER 2

Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations



Member State

Territory

Bulgaria

Whole territor

Croatia

Whole territory

Greece

Whole territory

▼M6

Italy

Regione Basilicata

Regione Calabria: Provincia di Crotone, Reggio Calabria, Vibo Valentia

Regione Campania: Provincia di Caserta, Avellino

Regione Puglia: Provincia di Foggia

Regione Sicilia

▼M3

Portugal

Região Madeira

Distritos Aveiro, Beja, Braga, Braganca, Castelo Branco, Coimbra, Evora, Faro, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu

▼B




ANNEX II

INFECTION WITH MYCOBACTERIUM TUBERCULOSIS COMPLEX (M. BOVIS, M. CAPRAE AND M. TUBERCULOSIS) (MTBC)

▼M4

PART I

Member States or zones thereof with disease-free status from infection with MTBC



Member State

Territory

Belgium

Whole territory

Czechia

Whole territory

Denmark

Whole territory

Germany

Whole territory

Estonia

Whole territory

▼M6

Spain

Comunidad Autónoma de Canarias

Comunidad Autónoma de Castilla y León: Province of Burgos, León, Valladolid

Comunidad Autónoma de Cataluña

Comunidad Autónoma de Galicia

Comunidad Autónoma de Islas Baleares

Comunidad Autónoma de Murcia

Comunidad Autónoma del País Vasco

Comunidad Autónoma del Principado de Asturias

▼M4

France

Whole territory

▼M6

Italy

Regione Abruzzo

Regione Basilicata: Provincia di Matera

Regione Calabria: Provincia di Catanzaro

Regione Campania: Provincia di Napoli

Regione Emilia-Romagna

Regione Friuli Venezia Giulia

Regione Lazio: Provincia di Frosinone, Latina, Rieti, Viterbo

Regione Liguria

Regione Lombardia

Regione Marche: Provincia di Ancona, Ascoli Piceno, Fermo, Pesaro-Urbino

Regione Molise

Regione Piemonte

Regione Puglia: Provincia di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto

Regione Sardegna: Città metropolitana di Cagliari, Provincia di Medio Campidano, Nord Est Sardegna, Nuoro, Ogliastra, Oristano, Sulcis Iglesiente

Regione Toscana

Regione Trentino – Alto Adige

Regione Umbria

Regione Valle d’Aosta

Regione Veneto

▼M4

Latvia

Whole territory

Lithuania

Whole territory

Luxembourg

Whole territory

Hungary

Whole territory

Netherlands

Whole territory

Austria

Whole territory

Poland

Whole territory

Portugal

Região Algarve: all distritos

Região Autónoma dos Açores except Ilha de São Miguel

Slovenia

Whole territory

Slovakia

Whole territory

Finland

Whole territory

Sweden

Whole territory

PART II

Member States or zones thereof with an approved eradication programme for infection with MTBC



Member State (*1)

Territory

Bulgaria

Whole territory

Croatia

Whole territory

Cyprus

Whole territory

Greece

Whole territory

Ireland

Whole territory

▼M6

Italy

Regione Basilicata: Provincia di Potenza

Regione Calabria: Provincia di Cosenza, Crotone, Reggio Calabria, Vibo Valentia

Regione Campania: Provincia d’Avellino, Caserta, Benevento, Salerno

Regione Lazio: Provincia di Roma

Regione Marche: Provincia di Macerata

Regione Puglia: Provincia di Foggia

Regione Sardegna: Città metropolitana di Sassari

Regione Sicilia

▼M4

Malta

Whole territory

Portugal

Região Autónoma dos Açores: Ilha de São Miguel

Região Autónoma da Madeira

Distritos Aveiro, Beja, Braga, Bragança, Castelo Branco, Coimbra, Evora, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu

Romania

Whole territory

▼M6

Spain

Comunidad Autónoma de Andalucía

Comunidad Autónoma de Aragón

Comunidad Autónoma de Cantabria

Comunidad Autónoma de Castilla-La Mancha

Comunidad Autónoma de Castilla y León: Province of Ávila, Palencia, Salamanca, Segovia, Soria, Zamora

Comunidad Autónoma de Extremadura

Comunidad Autónoma de La Rioja

Comunidad Autónoma de Madrid

Comunidad Autónoma de Navarra

Comunidad Autónoma de Valencia

▼M4

United Kingdom (Northern Ireland)

Northern Ireland

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

▼B




ANNEX III

INFECTION WITH THE RABIES VIRUS (RABV)

PART I

Member States or zones thereof with disease-free status from infection with RABV



Member State (*1)

Territory

Belgium

Whole territory

Bulgaria

Whole territory

Czechia

Whole territory

Denmark

Whole territory

Germany

Whole territory

Estonia

Whole territory

Ireland

Whole territory

Greece

Whole territory

▼M3

Spain

Whole territory

France

Whole territory

▼B

Croatia

Whole territory

Italy

Whole territory

Cyprus

Whole territory

Latvia

Whole territory

Lithuania

Whole territory

Luxembourg

Whole territory

▼M5

Hungary

Whole territory except Szabolcs-Szatmár-Bereg megye

▼B

Malta

Whole territory

Netherlands

Whole territory

Austria

Whole territory

▼M3

Poland

Voivodship Dolnośląskie: all powiaty

Voivodship Kujawsko-pomorskie: all powiaty

Voivodship Lubelskie the following powiaty: m. Lublin, Łęczyński, Parczewski, Radzyński, Świdnicki

Voivodship Lubuskie: all powiaty

Voivodship Łódzkie the following powiaty: Bełchatowski, Brzeziński, Kutnowski, Łaski, Łęczycki, Łowicki, Łódzki Wschodni, m. Łódź, Pabianicki, Pajęczański, Piotrkowski, m. Piotrków Trybunalski, Poddębicki, Radomszczański, Rawski, Sieradzki, Skierniewicki, m. Skierniewice, Tomaszowski, Wieluński, Wieruszowski, Zduńskowolski, Zgierski

Voivodship Małopolskie: all powiaty

Voivodship Mazowieckie the following powiaty: Ciechanowski, Gostyniński, Makowski, Mławski, Ostrołęcki, m. Ostrołęka, Płocki, m. Płock, Przasnyski, Sierpecki, Żuromiński

Voivodship Opolskie: all powiaty

Voivodship Podlaskie: all powiaty

Voivodship Pomorskie: all powiaty

Voivodship Śląskie: all powiaty

Voivodship Świętokrzyskie the following powiaty: Buski, Kazimierski, Pińczowski, Włoszczowski

Voivodship Warmińsko-mazurskie: all powiaty

Voivodship Wielkopolskie: all powiaty

Voivodship Zachodniopomorskie: all powiaty

▼B

Portugal

Whole territory

Slovenia

Whole territory

▼M6

Slovakia

Whole territory, except the following regions:

Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský

Michalovce, Sobrance, Trebišov in kraj Košický

▼B

Finland

Whole territory

Sweden

Whole territory

United Kingdom (Northern Ireland)

Northern Ireland

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

▼M3

PART II

Member States or zones thereof with an approved eradication programme for infection with RABV



Member State

Territory

▼M5

Hungary

Szabolcs-Szatmár-Bereg megye

▼M3

Poland

Voivodship Lubelskie the following powiaty: Bialski, m. Biała Podlaska, Biłgorajski, Chełmski, m. Chełm, Hrubieszowski, Janowski, Krasnostawski, Kraśnicki, Lubartowski, Lubelski, Łukowski, Opolski, Puławski, Rycki, Tomaszowski, Włodawski, Zamojski, m. Zamość

Voivodship Łódzkie the following powiaty: Opoczyński

Voivodship Mazowieckie the following powiaty: Białobrzeski, Garwoliński, Grodziski, Grójecki, Kozienicki, Legionowski, Lipski, Łosicki, Miński, Nowodworski, Ostrowski, Otwocki, Piaseczyński, Płoński, Pruszkowski, Przysuski, Pułtuski, Radomski, m. Radom, Siedlecki, m. Siedlce, Sochaczewski, Sokołowski, Szydłowiecki, m.st. Warszawa, Warszawski Zachodni, Węgrowski, Wołomiński, Wyszkowski, Zwoleński, Żyrardowski

Voivodship Podkarpackie

Voivodship Świętokrzyskie the following powiaty: Jędrzejowski, Kielecki, m. Kielce, Konecki, Opatowski, Ostrowiecki, Sandomierski, Skarżyski, Starachowicki, Staszowski

Romania

Whole territory

▼M6

Slovakia

Region Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský

Region Michalovce, Sobrance, Trebišov in kraj Košický

▼B




ANNEX IV

ENZOOTIC BOVINE LEUKOSIS (EBL)

PART I

Member States or zones thereof with disease-free status from EBL



Member State (*1)

Territory

Belgium

Whole territory

Czechia

Whole territory

Denmark

Whole territory

Germany

Whole territory

Estonia

Whole territory

Ireland

Whole territory

Spain

Whole territory

France

Région Auvergne et Rhône-Alpes

Région Bourgogne-Franche-Comté

Région Bretagne

Région Centre-Val de Loire

Région Corse

Région Grande Est

Région Hauts-de-France

Région Ile-de-France

Région Normandie

Région Nouvelle-Aquitaine

Région Occitanie

Région Pays de la Loire

Région Provence-Alpes-Côte d’Azur

Région Guadeloupe

Région Guyane

Région Martinique

Région Mayotte

Italy

Whole territory

Cyprus

Whole territory

Latvia

Whole territory

Lithuania

Whole territory

Luxembourg

Whole territory

Netherlands

Whole territory

Austria

Whole territory

Poland

Whole territory

▼M6

Portugal

Whole territory, except Região Autónoma da Madeira

▼B

Slovenia

Whole territory

Slovakia

Whole territory

Finland

Whole territory

Sweden

Whole territory

United Kingdom (Northern Ireland)

Northern Ireland

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

▼M4

PART II

Member States or zones thereof with an approved eradication programme for EBL



Member State

Territory

Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689

Croatia

Whole territory

18 July 2022

▼B




ANNEX V

INFECTIOUS BOVINE RHINOTRACHEITIS/INFECTIOUS PUSTULAR VULVOVAGINITIS (IBR/IPV)

PART I

Member States or zones thereof with disease-free status from IBR/IPV



Member State

Territory

Czechia

Whole territory

Denmark

Whole territory

Germany

Whole territory

Italy

Regione Valle d’Aosta

Regione Trentino – Alto Adige: Provincia Autonoma di Bolzano – Alto Adige

Austria

Whole territory

Finland

Whole territory

Sweden

Whole territory

PART II

Member States or zones thereof with an approved eradication programme for IBR/IPV



Member State

Territory

Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689

Belgium

Whole territory

21 April 2021

France

Région Auvergne et Rhône-Alpes

Région Bourgogne-Franche-Comté

Région Bretagne

Région Centre-Val de Loire

Région Grande Est

Région Hauts-de-France

Région Ile-de-France

Région Normandie

Région Nouvelle-Aquitaine

Région Occitanie

Région Pays de la Loire

Région Provence-Alpes-Côte d’Azur

21 April 2021

Italy

Region Friuli Venezia Giulia

Regione Trentino – Alto Adige: Provincia Autonoma di Trento

21 April 2021

Luxembourg

Whole territory

21 April 2021

▼M6

Slovakia

Kraj Bratislava

Kraj Košice

Kraj Prešov

Kraj Trnava

Kraj Žilina

5 June 2023

▼B




ANNEX VI

AUJESZKY’S DISEASE VIRUS (ADV)

PART I

Member States or zones thereof with disease-free status from infection with ADV



Member State (*1)

Territory

Belgium

Whole territory

Czechia

Whole territory

Denmark

Whole territory

Germany

Whole territory

Estonia

Whole territory

Ireland

Whole territory

France

The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Côtes-d’Armor, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Finistère, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Ille-et-Vilaine, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Morbihan, Moselle, Nièvre, Nord, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines

▼M5

Italy

Regione Friuli Venezia Giulia

Regione Trentino – Alto Adige

Regione Veneto

▼B

Cyprus

Whole territory

Luxembourg

Whole territory

Hungary

Whole territory

Netherlands

Whole territory

Austria

Whole territory

▼M6

Poland

Whole territory

▼B

Slovenia

Whole territory

Slovakia

Whole territory

Finland

Whole territory

Sweden

Whole territory

United Kingdom (Northern Ireland)

Northern Ireland

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States or zones thereof with an approved eradication programme for infection with ADV



Member State

Territory

Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689

Spain

Whole territory

21 April 2021

▼M5

Italy

Regione Abruzzo

Regione Apulia

Regione Basilicata

Regione Calabria

Regione Campania

Regione Emilia-Romagna

Regione Lazio

Regione Liguria

Regione Lombardia

Regione Marche

Regione Molise

Regione Piemonte

Regione Sicilia

Regione Toscana

Regione Valle d’Aosta

Regione Umbria

21 April 2021

▼B

Lithuania

Whole territory

21 April 2021

▼M6 —————

▼B

Portugal

Whole peninsular territory

21 April 2021




ANNEX VII

BOVINE VIRAL DIARRHOEA (BVD)

▼M4

PART I

Member States or zones thereof with disease-free status from BVD



Member State

Territory

Austria

Whole territory

Denmark

Whole territory

Finland

Whole territory

▼M6

Germany

Bundesland Baden-Württemberg

Bundesland Bayern:

Regierungsbezirk Oberbayern

The following cities and Landkreis in Regierungsbezirk Niederbayern: Stadt Landshut, Stadt Passau, Stadt Straubing, Freyung-Grafenau, Kelheim, Lkr. Landshut, Lkr. Passau, Regen, Rottal-Inn, Lkr. Straubing-Bogen,

Regierungsbezirk Mittelfranken

Regierungsbezirk Oberfranken

Regierungsbezirk Oberpfalz

Regierungsbezirk Unterfranken

Regierungsbezirk Schwaben

Bundesland Brandenburg

Bundesland Bremen

Bundesland Hamburg

Bundesland Hessen

Bundesland Mecklenburg-Vorpommern

Bundesland Rheinland-Pfalz

Bundesland Saarland

Bundesland Sachsen

Bundesland Sachsen-Anhalt

Bundesland Thüringen

▼M4

Sweden

Whole territory

PART II

Member States or zones thereof with an approved eradication programme for BVD



Member State

Territory

Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689

▼M6

Germany

Bundesland Bayern:

The following cities and Landkreis in Regierungsbezirk Niederbayern: Deggendorf, Dingolfing-Landau

Bundesland Berlin

Bundesland Niedersachsen

Bundesland Nordrhein-Westfalen

Bundesland Schleswig-Holstein

21 February 2022

▼M4

Ireland

Whole territory

18 July 2022

▼B




ANNEX VIII

INFECTION WITH BLUETONGUE VIRUS (BTV)

PART I

Member States or zones thereof with disease-free status from infection with BTV



Member State (*1)

Territory

▼M6

Belgium

Whole territory

▼B

Czechia

Whole territory

Denmark

Whole territory

▼M6

Germany

Whole territory

▼B

Estonia

Whole territory

Ireland

Whole territory

▼M6

Spain

Comunidad Autónoma de Andalucía: Province of Almería

Province of Granada, the following districts: Alhama de Granada (Alhama/Temple), Baza (Altiplanicie Sur), Guadix (Hoya-Altiplanicie de Guadix), Huescar (Altiplanicie Norte), Iznalloz (Montes Orientales), Loja (Vega/Montes Occ.), Orgiva (Alpujarra/Valle de Lecrin), Santa Fe (Vega de Granada)

Comunidad Autónoma de Aragón

Comunidad Autónoma de Asturias

Comunidad Autónoma de Canarias Comunidad Autónoma de Cantabria

Comunidad Autónoma de Castilla-La Mancha, except the following districts:

Almadén, Almodóvar del Campo, Piedrabuena in the Province of Ciudad Real

Belvis de la Jara, Gálvez, Los Navalmorales, Oropesa, Talavera de la Reina, Toledo, Torrijos in the Province of Toledo

Comunidad Autónoma de Castilla y León, except the following areas:

Province of Salamanca

Ávila, Arenas de San Pedro, Candeleda, Cebrero, El Barco de Ávila, El Barraco, Navaluenga, Navarredonda de Gredos, Piedrahíta, San Pedro del Arroyo, Sotillo de la Adrada in the Province of Ávila

Alcañices, Bermillo de Sayago, Puebla de Sanabria in the Province of Zamora

Comunidad Autónoma de Cataluña

Comunidad Autónoma de Galicia except the following areas:

Province of Orense

Province of Pontevedra

Sarria, Chantada and Terra de Lemos-Quiroga in the Province of Lugo

Comunidad Autónoma de La Rioja

Comunidad Autónoma de Madrid, except the following districts:

Navalcarnero, San Martín de Valdeiglesias

Comunidad Autónoma de Murcia

Comunidad Autónoma de Navarra

Comunidad Autónoma de País Vasco

Comunidad Autónoma de Valencia

▼M1

Italy

Provincia Autonoma di Bolzano – Alto Adige

Regione Valle d’Aosta

Regione Friuli Venezia Giulia

▼B

Latvia

Whole territory

▼M1

Lithuania

Whole territory

▼B

Hungary

Whole territory

Netherlands

Whole territory

Austria

Whole territory

Poland

Whole territory

▼M5

Portugal

Região Autónoma dos Açores

Região Autónoma da Madeira

▼B

Slovenia

Whole territory

Slovakia

Whole territory

Finland

Whole territory

Sweden

Whole territory

United Kingdom (Northern Ireland)

Northern Ireland

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

▼M6

PART II

Member States or zones thereof with an approved eradication programme for infection with BTV



Member State

Territory

Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689

Spain

Communidad Autónoma de Andalucía:

Provinces of Cádiz, Córdoba, Huelva, Jáén, Málaga, Sevilla

Province of Granada: Motril (Costa de Granada)

Communidad Autónoma de Castilla-La Mancha:

Province of Ciudad Real, the following districts: Almadén, Almodóvar del Campo and Piedrabuena

Province of Toledo, the following districts: Belvis de la Jara, Gálvez, Los Navalmorales, Oropesa, Talavera de la Reina, Toledo, Torrijos

Comunidad Autónoma de Castilla y León:

Province of Salamanca

Province of Ávila, the following districts: Ávila, Arenas de San Pedro, Candeleda, Cebrero, El Barco de Ávila, El Barraco, Navaluenga, Navarredonda de Gredos, Piedrahíta, San Pedro del Arroyo, Sotillo de la Adrada

Province of Zamora, the following districts: Alcañices, Bermillo de Sayago Puebla de Sanabria

Communidad Autónoma de Extremadura

Communidad Autónoma de Galicia:

Province of Orense

Province of Pontevedra

Sarria, Chantada and Terra de Lemos-Quiroga in the Province of Lugo

Communidad Autónoma de Islas Baleares

Comunidad Autónoma de Madrid, the following districts:

Navalcarnero, San Martín de Valdeiglesias

21 February 2022

▼B




ANNEX IX

INFESTATION WITH VARROA SPP.

Member States or zones thereof with disease-free status from infestation with Varroa spp.



Member State

Territory

Portugal

Island of Corvo

Island of Graciosa

Island of São Jorge

Island of Santa Maria

Island of São Miguel

Island of Terceira

▼M2

Finland

Åland Islands, except the municipality of Brändö

▼B




ANNEX X

INFECTION WITH NEWCASTLE DISEASE VIRUS

Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination



Member State

Territory

Finland

Whole territory

Sweden

Whole territory




ANNEX XI

HIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI)

Compartments free from HPAI



Member State

Name

France

Compartiment ISA Bretagne comprising the establishments with codes EDE 22080055, 22277180, 22203429, 22059174 and 22295000.

Compartiment SASSO Sabres comprising the establishment with Code EDE 40246082.

Compartiment SASSO Soulitré comprising the establishment with Code EDE 72341105.

Netherlands

Verbeek’s poultry international B.V with approval number 1122.

Institut de selection animale B.V with approval number 2338.

Cobb Europe B.V. with approval number 2951.




ANNEX XII

VIRAL HAEMORRHAGIC SEPTICAEMIA (VHS)

PART I

Member States whose whole territory has disease-free status from VHS;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and

zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



Member State (*1)

Territory

Denmark

Whole continental territory

Ireland

Whole territory

Cyprus

Whole continental territory

▼M5

Finland

Whole territory

▼B

Sweden

Whole territory

United Kingdom (Northern Ireland)

Northern Ireland

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States where their whole territory has an approved eradication programme for VHS;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS;

and zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



Member State

Territory

Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689

Estonia

Whole territory

21 April 2021




ANNEX XIII

INFECTIOUS HAEMATOPOIETIC NECROSIS (IHN)

PART I

Member States where their whole territory has disease-free status from IHN;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN;

and zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



Member State (*1)

Territory

▼M3 —————

▼B

Ireland

Whole territory

Cyprus

Whole continental territory

▼M5

Finland

Whole territory, except for the following:

1)  the coastal compartment comprised of the parts of Föglö, Lumparland, Lemland, Vårdö municipalities that are contained within a circle of radius 19,331 km, centered on WGS84 coordinates Lat 59.975253701°, Lon 20.454027317°

2)  the coastal compartment comprised of the parts of Eckerö and Hammarland municipalities that are contained within a circle of radius 10 km, centered on WGS84 coordinates Lat 60.207175390°, Lon 19.507907780°

▼B

Sweden

Whole territory

United Kingdom (Northern Ireland)

Northern Ireland

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States where their whole territory has an approved eradication programme for IHN;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and

zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



Member State

Territory

Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689

Estonia

Whole territory

21 April 2021




ANNEX XIV

INFECTION WITH HIGHLY POLYMORPHIC REGION DELETED INFECTIOUS SALMON ANAEMIA VIRUS (HPR-DELETED ISAV)

PART I

Member States where their whole territory has disease-free status from infection with HPR-deleted ISAV;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and

zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



Member State (*1)

Territory

Belgium

Whole territory

Bulgaria

Whole territory

Czechia

Whole territory

Denmark

Whole territory

Germany

Whole territory

Estonia

Whole territory

Ireland

Whole territory

Greece

Whole territory

Spain

Whole territory

France

Whole territory

Croatia

Whole territory

Italy

Whole territory

Cyprus

Whole territory

Latvia

Whole territory

Lithuania

Whole territory

Luxembourg

Whole territory

Hungary

Whole territory

Malta

Whole territory

Netherlands

Whole territory

Austria

Whole territory

Poland

Whole territory

Portugal

Whole territory

Romania

Whole territory

Slovenia

Whole territory

Slovakia

Whole territory

Finland

Whole territory

Sweden

Whole territory

United Kingdom (Northern Ireland)

Northern Ireland

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and

zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.




ANNEX XV

INFECTION WITH MARTEILIA REFRINGENS

PART I

Member States where their whole territory has disease-free status from infection with Marteilia refringens;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and

zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



Member State (*1)

Territory

Ireland

Whole territory

United Kingdom (Northern Ireland)

The whole coastline of Northern Ireland, except for Belfast Lough and Dundrum Bay.

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and

zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.




ANNEX XVI

INFECTION WITH BONAMIA EXITIOSA

PART I

Member States where their whole territory has disease-free status from infection with Bonamia exitiosa;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and

zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



Member State

Territory

Estonia

Whole territory

PART II

Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and

zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.




ANNEX XVII

INFECTION WITH BONAMIA OSTREAE

PART I

Member States where their whole territory has disease-free status from infection with Bonamia ostreae;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and

zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



Member State (*1)

Territory

Estonia

Whole territory

Ireland

The whole coastline of Ireland, except: Cork Harbour; Galway Bay; Ballinakill Harbour; Clew Bay; Achill Sound; Loughmore, Blacksod Bay; Lough Foyle; Lough Swilly; and Kilkieran Bay.

United Kingdom (Northern Ireland)

The whole coastline of Northern Ireland, except: Lough Foyle and Strangford Lough.

(*1)   

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and

zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.




ANNEX XVIII

INFECTION WITH WHITE SPOT SYNDROME VIRUS (WSSV)

PART I

Member States where their whole territory has disease-free status from infection with WSSV;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and

zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.

PART II

Member States where their whole territory has an approved eradication programme for infection with WSSV;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and

zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.



( 1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Regulation references to Member States include the United Kingdom in respect of Northern Ireland.

Top